W
WAVEMAN · COMPANY
ACON · Aclarion, Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

ACON

Aclarion, Inc.
HEALTHCARE SERVICES · SERVICES-MEDICAL LABORATORIES · CIK 0001635077
CLUSTER · 7 INSIDERSC-SUITE BUYING · 2☆ WATCH
INSIDER NET · 180D
$176.6K
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
7
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
10
13F, latest reported quarter
REVENUE GROWTH
+65.6%
XBRL, annual
NET MARGIN
-
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net +$176.6K over 180 days
+$125.7K over 90 days
more than 78% of Healthcare Services
CONGRESS
no member of Congress has reported trading it
FUNDS
10 funds added or opened last quarter
below 93% of Healthcare Services
REVENUE
+65.6% year over year
more than 92% of Healthcare Services
MARGIN
no margin: this company reports no revenue to divide by
BUYBACKS
no share repurchases reported
SHORT
1.1% of shares outstanding short · 1.0 days to cover · settled 2026-07-31
below 69% of Healthcare Services
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
7 insiders independently bought a net $176.6K while the stock fell 25% over six months — no planned sales are queued against it.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -67.1%
-67.1%12M
-72%-36%-0%+36%2025-092025-102025-122026-032026-052026-072026-09 2026-08-13 · Bond Ryan bought $50.1K2026-08-14 · Gould Gregory A bought $24.5K2026-05-11 · Ness Brent bought $20.0K2026-05-12 · Breidbart Scott bought $18.0K2026-08-13 · Neal David K bought $18.0K2026-08-17 · Williams Amanda M bought $16.0K2026-08-13 · Ness Brent bought $12.1K2026-05-11 · Neal David K bought $7.8K2026-05-06 · Wesemann William bought $5.2K2026-08-13 · Wesemann William bought $5.0K2025-11-26 · Ness Brent bought $62
INSIDER BUY
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
7 insiders reported buying shares.
The record shows a net $176.6K bought by insiders over 180 days, 10 funds added last quarter. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Aclarion, Inc. insiders bought a net $176.6K of stock across 21 Form 4 purchases and sales, with 7 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
Williams Amanda M
Director
BUY
2026-08-17
5,857.0
$16.0K
Gould Gregory A
CFO
BUY
2026-08-14
10,000.0
$24.5K
Bond Ryan
Director
BUY
2026-08-13
21,122.0
$50.1K
Wesemann William
Director
BUY
2026-08-13
2,150.0
$5.0K
Neal David K
Director
BUY
2026-08-13
7,500.0
$18.0K
21 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 16 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
BRIDGEWAY CAPITAL MANAGEMENT, LLC
19,480.0 sh
$56.1K
CAPTRUST FINANCIAL ADVISORS
95,459.0 sh
$50.8K
VANGUARD FIDUCIARY TRUST CO
16,028.0 sh
$46.2K
SUSQUEHANNA INTERNATIONAL GROUP, LLP
15,355.0 sh
$44.2K
GEODE CAPITAL MANAGEMENT, LLC
12,128.0 sh
$34.9K
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Fidelity Extended Market Index Fund
$29.2K POSITION · AS OF 2026-02-28
0.0%
VANGUARD EXTENDED MARKET INDEX FUND
$22.2K POSITION · AS OF 2026-03-31
0.0%
Fidelity Series Total Market Index Fund
$1.3K POSITION · AS OF 2026-02-28
0.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Clinical pipeline
ClinicalTrials.gov · 1 registered trials, 1 still enrolling or running — a status change here is dated weeks before the press release
1
Not applicable
1 ACTIVE
TRIALS MATCHED TO THIS TICKER BY SPONSOR NAME · STUDIES RUN UNDER A SUBSIDIARY'S OWN NAME ARE NOT INCLUDED
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$75.7K$45.7K$75.4K$60.4K
GROSS PROFIT$6.8K$-38.9K$-324$-4.9K
OPERATING INCOME$-7.1M$-5.5M$-4.9M$-5.6M
NET INCOME$-7.2M$-7.0M$-4.9M$-7.1M
EPS (DILUTED)-13.61-7,478.90-79,782.00-19.61
OPERATING CASH FLOW$-7.2M$-5.3M$-3.6M$-4.9M
CASH$12.0M$453.7K$1.0M$1.5M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →